---
document_datetime: 2023-09-21 20:31:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/novoseven-epar-all-authorised-presentations_en.pdf
document_name: novoseven-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0135586
conversion_datetime: 2025-12-25 08:08:29.34241
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength       | Pharmaceutical                                | Route of        | Immediate                                      | Content                                          | Pack size                           |
|------------------|--------------|----------------|-----------------------------------------------|-----------------|------------------------------------------------|--------------------------------------------------|-------------------------------------|
|                  | name         |                | form                                          | administration  | Packaging                                      | (concentration)                                  |                                     |
| EU/1/96/006/008  | NovoSeven    | 1 mg (50 KIU)  | Powder and solvent for solution for injection | Intravenous use | powder: vial (glass); solvent: syringe (glass) | powder: 1 mg (50 KIU); (50 KIU/ml); solv.: 1 ml  | 1 vial + 1 syringe + 1 vial adapter |
| EU/1/96/006/009  | NovoSeven    | 2 mg (100 KIU) | Powder and solvent for solution for injection | Intravenous use | powder: vial (glass); solvent: syringe (glass) | powder: 2 mg (100 KIU); (50 KIU/ml); solv.: 2 ml | 1 vial + 1 syringe + 1 vial adapter |
| EU/1/96/006/010  | NovoSeven    | 5 mg (250 KIU) | Powder and solvent for solution for injection | Intravenous use | powder: vial (glass); solvent: syringe (glass) | powder: 5 mg (250 KIU); (50 KIU/ml) solv.: 5 ml  | 1 vial + 1 syringe + 1 vial adapter |
| EU/1/96/006/011  | NovoSeven    | 8 mg (400 KIU) | Powder and solvent for solution for injection | Intravenous use | powder: vial (glass); solvent: syringe (glass) | powder: 8 mg (400 KIU); (50 KIU/ml) solv.: 8 ml  | 1 vial + 1 syringe + 1 vial adapter |